Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-069921
Filing Date
2022-03-09
Accepted
2022-03-09 07:46:33
Documents
5
Effectiveness Date
2022-03-09

Document Format Files

Seq Description Document Type Size
1 S-8 d314740ds8.htm S-8 32747
2 EX-5.1 d314740dex51.htm EX-5.1 6513
3 EX-23.1 d314740dex231.htm EX-23.1 1393
4 EX-FILING FEES d314740dexfilingfees.htm EX-FILING FEES 16545
5 GRAPHIC g314740g0308145524300.jpg GRAPHIC 2747
  Complete submission text file 0001193125-22-069921.txt   62122
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263380 | Film No.: 22723933
SIC: 2836 Biological Products, (No Diagnostic Substances)